• to decreased the risk of major cardiovascular (heart and blood vessel) challenges in Grown ups with kind 2 diabetes and heart problemsThis led Novo Nordisk to carry out further more investigation into bigger dosages of semaglutide especially for weight management.Wegovy, on the other hand, is authorised via the FDA specifically for weight manag